Environmental risk assessment for human and veterinary medicinal products.(Regulatory Action and News)

European Union -- The European Medicines Agency held a conference with interested parties on 27-28 October 2005 to discuss the current state and future developments in the area of environmental risk assessment for human and veterinary medicinal products.

Medicinal products used for the treatment of humans or animals may have an impact on the environment. The new EU pharmaceutical legislation requires companies to submit an environmental risk assessment as part of a marketing authorization application.

More than 130 participants from the Agency's Committee for Medicinal Products for Human Use (CHMP) and Committee for Medicinal Products for Veterinary Use (CVMP), the Committees' Working Parties, national competent …